Covalon to Present at the 2026 Annual Smallcap Discoveries Conference After Reporting Revenue Growth of 20% and Gross Margin of 67%

Stock Information for Covalon Technologies Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Covalon Technologies Ltd.

Covalon Reports Fiscal 2026 Third Quarter Results
Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2026 Results
Covalon Announces Appointment of New Director and DSU Grants
Covalon Reports 2026 Second Quarter Results
Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2026 Results
Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care
Covalon to Showcase Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting
Covalon Announces Grant of Deferred Share Units

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.